X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with Aventis Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs SANOFI INDIA - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS SANOFI INDIA J.B.CHEMICALS/
SANOFI INDIA
 
P/E (TTM) x 15.1 34.3 44.0% View Chart
P/BV x 2.4 6.5 36.5% View Chart
Dividend Yield % 0.2 1.4 11.8%  

Financials

 J.B.CHEMICALS   SANOFI INDIA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
SANOFI INDIA
Dec-16
J.B.CHEMICALS/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs3184,560 7.0%   
Low Rs2004,400 4.5%   
Sales per share (Unadj.) Rs148.01,028.5 14.4%  
Earnings per share (Unadj.) Rs19.1129.0 14.8%  
Cash flow per share (Unadj.) Rs23.9186.0 12.9%  
Dividends per share (Unadj.) Rs0.5068.00 0.7%  
Dividend yield (eoy) %0.21.5 12.7%  
Book value per share (Unadj.) Rs128.9753.6 17.1%  
Shares outstanding (eoy) m84.8223.03 368.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.74.4 40.2%   
Avg P/E ratio x13.634.7 39.0%  
P/CF ratio (eoy) x10.824.1 44.9%  
Price / Book Value ratio x2.05.9 33.8%  
Dividend payout %2.652.7 5.0%   
Avg Mkt Cap Rs m21,951103,174 21.3%   
No. of employees `0002.73.6 75.5%   
Total wages/salary Rs m1,8413,592 51.3%   
Avg. sales/employee Rs Th4,590.96,537.7 70.2%   
Avg. wages/employee Rs Th673.4991.4 67.9%   
Avg. net profit/employee Rs Th592.1819.8 72.2%   
INCOME DATA
Net Sales Rs m12,55123,686 53.0%  
Other income Rs m542708 76.5%   
Total revenues Rs m13,09324,394 53.7%   
Gross profit Rs m2,0555,281 38.9%  
Depreciation Rs m4121,313 31.4%   
Interest Rs m9615 638.0%   
Profit before tax Rs m2,0884,661 44.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4691,691 27.7%   
Profit after tax Rs m1,6192,970 54.5%  
Gross profit margin %16.422.3 73.4%  
Effective tax rate %22.536.3 61.9%   
Net profit margin %12.912.5 102.9%  
BALANCE SHEET DATA
Current assets Rs m7,77815,673 49.6%   
Current liabilities Rs m4,3586,678 65.3%   
Net working cap to sales %27.238.0 71.7%  
Current ratio x1.82.3 76.0%  
Inventory Days Days5576 71.9%  
Debtors Days Days8022 358.6%  
Net fixed assets Rs m5,7138,098 70.5%   
Share capital Rs m170230 73.6%   
"Free" reserves Rs m10,54717,088 61.7%   
Net worth Rs m10,93717,356 63.0%   
Long term debt Rs m00-   
Total assets Rs m15,57425,400 61.3%  
Interest coverage x22.8311.7 7.3%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.9 86.4%   
Return on assets %11.011.8 93.7%  
Return on equity %14.817.1 86.5%  
Return on capital %20.026.9 74.1%  
Exports to sales %48.724.5 198.9%   
Imports to sales %7.128.0 25.3%   
Exports (fob) Rs m6,1155,801 105.4%   
Imports (cif) Rs m8896,627 13.4%   
Fx inflow Rs m6,1697,145 86.3%   
Fx outflow Rs m1,2856,846 18.8%   
Net fx Rs m4,884299 1,633.4%   
CASH FLOW
From Operations Rs m1,3973,226 43.3%  
From Investments Rs m-320-1,555 20.6%  
From Financial Activity Rs m-1,196-1,818 65.8%  
Net Cashflow Rs m-102-147 69.6%  

Share Holding

Indian Promoters % 55.4 0.0 -  
Foreign collaborators % 0.3 60.4 0.5%  
Indian inst/Mut Fund % 3.4 14.4 23.5%  
FIIs % 3.9 14.6 26.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 10.5 352.4%  
Shareholders   30,437 15,184 200.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   CADILA HEALTHCARE  TTK HEALTHCARE  ORCHID PHARMA LTD  DISHMAN PHARMA  FULFORD INDIA  

Compare J.B.CHEMICALS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Markets Rebound After Sharp Weekly Drop(RoundUp)

Global financial markets rallied this week and brushed aside a rise in global borrowing costs while the dollar hit its lowest level since 2014.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

As the Market Corrects... It's Time to Buy More(Smart Contrarian)

Feb 5, 2018

The recent sell off in the stock market offers buying opportunity in some quality small caps.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

What Should Mutual Fund Investors Do After LTCG Tax Norms(Outside View)

Feb 6, 2018

PersonalFN explain what investors should after LTCG tax norms.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Feb 16, 2018 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 5-YR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS